Human Papillomavirus (HPV) Clinical Trials

5 recruiting

Human Papillomavirus (HPV) Trials at a Glance

7 actively recruiting trials for human papillomavirus (hpv) are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Aberdeen, Adana, and Adana. Lead sponsors running human papillomavirus (hpv) studies include DL Analytics, Emel GÜÇLÜ CİHAN, and Cukurova University.

Browse human papillomavirus (hpv) trials by phase

Treatments under study

About Human Papillomavirus (HPV) Clinical Trials

Looking for clinical trials for Human Papillomavirus (HPV)? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Human Papillomavirus (HPV) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Human Papillomavirus (HPV) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions

Health Knowledge, Attitudes, PracticeHealth BehaviorHuman Papillomavirus (HPV)+2 more
Cukurova University88 enrolled2 locationsNCT07248904
Recruiting

The Role of Circulating Tumour DNA in Head and Neck Cancer

Oropharyngeal Squamous Cell CarcinomaHuman Papillomavirus (HPV)
University of Edinburgh250 enrolled5 locationsNCT05539638
Recruiting
Not Applicable

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Cervical CancerHuman Papillomavirus (HPV) InfectionHuman Immunodeficiency Virus (HIV) Infection
University of California, Irvine420 enrolled1 locationNCT07209917
Recruiting
Phase 4

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas69 enrolled1 locationNCT05334706
Recruiting
Not Applicable

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Human Papillomavirus (HPV) InfectionHPV Vaccination Acceptance/Intention
Emel GÜÇLÜ CİHAN117 enrolled1 locationNCT07420556
Recruiting
Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Uterine Cervical NeoplasmsCervical CancersCervical Intraepithelial Neoplasia+1 more
DL Analytics10,000 enrolled1 locationNCT06815939
Recruiting
Not Applicable

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

Cervical CancerCervical Cancer ScreeningCervical Intraepithelial Neoplasia+1 more
Karolinska Institutet1,000 enrolled1 locationNCT07275333